Sergio Veloso

633 total citations
10 papers, 199 citations indexed

About

Sergio Veloso is a scholar working on Infectious Diseases, Hepatology and Virology. According to data from OpenAlex, Sergio Veloso has authored 10 papers receiving a total of 199 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Hepatology and 3 papers in Virology. Recurrent topics in Sergio Veloso's work include Hepatitis C virus research (4 papers), HIV/AIDS drug development and treatment (4 papers) and HIV Research and Treatment (3 papers). Sergio Veloso is often cited by papers focused on Hepatitis C virus research (4 papers), HIV/AIDS drug development and treatment (4 papers) and HIV Research and Treatment (3 papers). Sergio Veloso collaborates with scholars based in Spain, Chile and United States. Sergio Veloso's co-authors include Francesc Vidal, Iñaki Pérez, Javier Murillas, Carmen Luna, Lucía Bonet, Montserrat Laguno, Joan Vendrell, José María Gatell, Peré Domingo and Josep Mallolas and has published in prestigious journals such as Hepatology, Clinical Microbiology and Infection and European Journal of Clinical Investigation.

In The Last Decade

Sergio Veloso

9 papers receiving 191 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sergio Veloso Spain 7 122 121 73 42 40 10 199
Yann Quertainmont France 7 64 0.5× 114 0.9× 85 1.2× 35 0.8× 37 0.9× 14 200
Kevin R. Frost United States 7 62 0.5× 117 1.0× 187 2.6× 117 2.8× 31 0.8× 9 276
Hedda Hoel Norway 9 58 0.5× 86 0.7× 59 0.8× 41 1.0× 95 2.4× 16 241
Montse Laguno Spain 4 79 0.6× 83 0.7× 96 1.3× 43 1.0× 67 1.7× 4 181
E. Wilkins United Kingdom 5 59 0.5× 76 0.6× 111 1.5× 71 1.7× 54 1.4× 7 190
Berend J. van Welzen Netherlands 9 58 0.5× 78 0.6× 136 1.9× 98 2.3× 75 1.9× 26 216
Paolo Tundo Italy 7 58 0.5× 84 0.7× 127 1.7× 83 2.0× 31 0.8× 10 201
Tianjun Jiang China 10 54 0.4× 82 0.7× 97 1.3× 38 0.9× 9 0.2× 21 227
Rui Sarmento‐Castro Portugal 8 34 0.3× 81 0.7× 80 1.1× 54 1.3× 36 0.9× 18 180
Andrea Andolina Italy 7 42 0.3× 53 0.4× 60 0.8× 16 0.4× 16 0.4× 13 108

Countries citing papers authored by Sergio Veloso

Since Specialization
Citations

This map shows the geographic impact of Sergio Veloso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Veloso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Veloso more than expected).

Fields of papers citing papers by Sergio Veloso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Veloso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Veloso. The network helps show where Sergio Veloso may publish in the future.

Co-authorship network of co-authors of Sergio Veloso

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Veloso. A scholar is included among the top collaborators of Sergio Veloso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Veloso. Sergio Veloso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Veloso, Sergio, et al.. (2023). Impuesto al valor agregado a los servicios. 8–12.
2.
Pérez‐Latorre, Leire, Juan Berenguer, Rafael Micán, et al.. (2021). HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018. Eurosurveillance. 26(25). 6 indexed citations
3.
Peraire, Joaquim, Miguel López-Dupla, Verònica Alba, et al.. (2015). HIV/antiretroviral therapy–related lipodystrophy syndrome (HALS) is associated with higher RBP4 and lower omentin in plasma. Clinical Microbiology and Infection. 21(7). 711.e1–711.e8. 8 indexed citations
4.
Escoté, Xavier, Ana Megía, Miguel López-Dupla, et al.. (2011). A study of fatty acid binding protein 4 in HIV-1 infection and in combination antiretroviral therapy-related metabolic disturbances and lipodystrophy. HIV Medicine. 12(7). 428–437. 14 indexed citations
5.
Laufer, Natalia, Montserrat Laguno, Iñaki Pérez, et al.. (2008). Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirin.. PubMed. 13(7). 953–7. 24 indexed citations
6.
Ferrer, Elena, José María Gatell, Peré Domingo, et al.. (2008). Zidovudine/Lamivudine/Abacavir Plus Tenofovir in HIV-Infected Naive Patients: A 96-Week Prospective One-Arm Pilot Study. AIDS Research and Human Retroviruses. 24(7). 931–934. 6 indexed citations
7.
Laufer, Natalia, Montserrat Laguno, Iñaki Pérez, et al.. (2008). Abacavir does not Influence the Rate of Virological Response in HIV–HCV-Coinfected Patients Treated with Pegylated Interferon and Weight-Adjusted Ribavirin. Antiviral Therapy. 13(7). 953–957. 21 indexed citations
9.
Domingo, Peré, Francesc Vidal, Joan Carles Domingo, et al.. (2005). Tumour necrosis factor alpha in fat redistribution syndromes associated with combination antiretroviral therapy in HIV‐1‐infected patients: potential role in subcutaneous adipocyte apoptosis. European Journal of Clinical Investigation. 35(12). 771–780. 36 indexed citations
10.
Vidal, Francesc, et al.. (2002). Coma vigil tras meningitis por Listeria monocytogenes. Enfermedades Infecciosas y Microbiología Clínica. 20(3). 127–128. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026